HYDERABAD, India , Nov. 29, 2022 /PRNewswire/ -- Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969® (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger number of subjects.
JB Chemicals & Pharmaceuticals Limited (JBCPL), one of the fastest growing pharmaceutical companies in India, has announced that it will acquire brands for the Indian market from Sanzyme Private Limited (Sanzyme), a leading player in the probiotics and reproductive health segment in the country.